Home News and events icddr,b in the news
icddr,b in the news

Our scientists and research outcomes are consistently featured by leading international media outlets, as illustrated by the stories below.

Please note that links are subject to the publisher’s archiving policy.

Showing 41 - 60 of 151

 
 
14 SEPTEMBER 2021
Eureka Alert

The study – the first of its kind to combine genome sequencing and mobile phone data – has found a direct link between mass migration from Dhaka, the capital of Bangladesh (an area of high infection), and the spread of coronavirus to the rest of the country after a stay-at-home order was announced during the nation’s first wave of infection in March 2020.

 
02 SEPTEMBER 2021
Devex

The study, conducted by the Stop TB Partnership and health research institute icddr,b, compared chest X-ray readings made by three certified radiologists in Dhaka with those done by five AI algorithms. The readings were then measured against the results of patients’ nucleic acid amplification tests, which were employed as the reference standard for TB diagnosis.

 
31 AUGUST 2021
France 24

Firdausi Qadri, 70, was one of five recipients of the Ramon Magsaysay Award -- named after a Filipino president killed in a plane crash -- for her "life-long devotion to the scientific profession" and "untiring contributions to vaccine development".

 
25 JULY 2021
Forbes Alert

Resistance to antibiotics is common and often deadly among children with pneumonia in Bangladesh, according to a new study coauthored by researchers from Massachusetts General Hospital (MGH) with colleagues at the International Centre for Diarrhoeal Disease Research, Bangladesh (abbreviated as icddr,b). This study, which appears in the journal Open Forum Infectious Diseases, offers an early warning that a pandemic of potentially deadly antibiotic resistance is under way and could spread around the globe.

 
08 JULY 2021
Newswise

One of the world’s leading global health research institutes, the International Centre for Diarrhoel Disease Research, Bangladesh, known as icddr,b, based in Dhaka, has collaborated on the project by helping to line up 1,500 people to participate in the trial. The app was developed in Bangla, the native language of the region.

 
05 MAY 2021
The World Health Organization

In recent weeks, the medical team at the UNICEF/icddr,b SARI ITC has been observing a decreasing number of patients seeking care in their dedicated isolation facility.

 
04 MAY 2021
Nature

“There is big demand for the Chinese vaccines,” says Firdausi Qadri, an immunologist at the International Centre for Diarrhoeal Disease Research, Bangladesh, in Dhaka.

 
30 APRIL 2021
SciDev

Friendly gut bacteria have emerged as an invaluable ally in the war against malnutrition after a research study in Bangladesh showed that bacteria-targeting food supplements were more effective than standard nutritional supplements in improving the health of undernourished children.

 
08 APRIL 2021
MSN

icddr,b observed a dramatic change in the distribution of SARS-CoV-2 variants when the South African variant appeared. It became the most prevalent variant during the third week of March 2021 by replacing other variants. Most remarkably, the South African variant occupied 81% of the variants in the fourth week of March 2021. Our findings warrant continuous monitoring of genetic variations of SARS-CoV-2, which is crucial for vaccine effectiveness and patients management.

 
08 APRIL 2021
Science Magazine

To save a starving child, aid workers have long used one obvious treatment: food. But a new study suggests feeding their gut bacteria may be as important—or even more important—than feeding their stomachs. In a head-to-head comparison against a leading treatment for malnutrition, a new supplement designed to promote helpful gut bacteria led to signs of improved growth and more weight gain, despite having 20% fewer calories. The study also highlights how important gut bacteria—the so-called microbiome—can be to human health.

 
29 MARCH 2021
FranceSoir

We continue our “World Tour” of treatments for COVID-19, with this Debriefing interview with Professor Wasif Ali Khan, in Bangladesh.

 
18 MARCH 2021
Mirage News

The B.1.1.7 variant of SARS-CoV-2, the UK variant, has been detected for the first time in a Bangladeshi resident. The research is published in Microbiology Resource Announcements, a journal of the American Society for Microbiology.

 
03 FEBRUARY 2021
Al Jazeera

As vaccination programmes in the developing world lag behind richer nations' efforts, a drug called ivermectin, commonly used for treating skin conditions and parasites in livestock, has shown some promise.

 
05 JANUARY 2021
Eureka Alert

A systematic review and meta-analysis of international COVID-19 literature, led by UNSW Sydney, has confirmed that while children under five years old were likely to recover from the infection, half of those infected were infants and almost half of the infected under-fives were asymptomatic.

 
16 DECEMBER 2020
Be The Hero Campaign

A "Be the Hero: Be the Change" blog about inspirational people who have stepped up to help

 
08 DECEMBER 2020
Anadolu Agency, Turkey

Patients who took only invermectin for 5 days 77% more likely to have early viral clearance after 14 days, says new study

 
28 NOVEMBER 2020
BBC

icddr,b's Senior Scientist Dr Firdausi Qadri gave an exclusive interview to BBC World Service's The Real Story on COVID-19 vaccines.

 
06 OCTOBER 2020
The Gates Notes

In 2011, Dr. Qadri and her team at the International Centre for Diarrheal Disease and Research, Bangladesh (icddr,b) led a feasibility study on a newer, more affordable oral cholera vaccine, Shanchol.

 
30 SEPTEMBER 2020
Eureka Alert

Tufts University will lead a $100 million, five-year program to understand and address threats posed by zoonotic viral diseases that can "spill over" from animals to humans, such as SARS-CoV-2, in an effort to reduce risk of infection, amplification, and spread, the United States Agency for International Development (USAID) announced today.

 
28 AUGUST 2020
The New York Times

Bangladesh has approved a late-stage trial of a potential COVID-19 vaccine developed by China's Sinovac Biotech Ltd in the hope of being a priority recipient for the jab, the health minister said on Thursday.



Showing 41 - 60 of 151